Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
The effects of curcumin supplementation on endothelial function: A systematic review and meta-analysis of randomized
Jamal Hallajzadeh1, Alireza Milajerdi2,3, Fariba Kolahdooz4
1Department of Biochemistry and Nutrition, Maraghe University of Medical Science, Maraghe, Iran.
Insights
Curcumin supplementation significantly improves flow-mediated dilation (FMD), a key indicator of endothelial function. However, it did not show significant effects on other cardiovascular disease risk markers like pulse wave velocity (PWV).
Area of Science:
- Cardiovascular Medicine
- Nutritional Science
- Pharmacology
Background:
- Endothelial dysfunction is a significant risk factor for cardiovascular disease (CVD).
- Curcumin, a compound found in turmeric, is being investigated for its potential cardiovascular benefits.
- Supplementation strategies are crucial for managing CVD risk factors.
Purpose of the Study:
- To systematically evaluate the impact of curcumin supplementation on endothelial function markers.
- To synthesize evidence from randomized controlled trials (RCTs) on curcumin's effects on CVD risk.
- To assess curcumin's influence on flow-mediated dilation (FMD), pulse wave velocity (PWV), and other endothelial markers.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, EMBASE, Scopus, Web of Science, Cochrane Library).
- Ten RCTs with 11 effect sizes were included in the meta-analysis.
- Cochrane Collaboration's risk of bias tool assessed study quality; random-effects models were used for data synthesis.
Main Results:
- Curcumin supplementation significantly increased flow-mediated dilation (FMD) (WMD: 1.49; 95% CI [0.16, 2.82]).
- No significant effects were observed on pulse wave velocity (PWV), augmentation index (Aix), endothelin-1 (ET-1), or soluble intercellular adhesion molecule-1 (sICAM-1).
- Heterogeneity was assessed using Cochran's Q test and I-square statistic.
Conclusions:
- Curcumin supplementation demonstrates a beneficial effect on improving endothelial function, specifically FMD.
- Curcumin did not significantly alter other key markers of vascular health, including PWV, Aix, ET-1, and sICAM-1.
- Further research may explore optimal dosing and specific populations for curcumin's cardiovascular benefits.
Abstract:
Impaired endothelial function is an important risk factor for cardiovascular disease (CVD). Curcumin supplementation might be an appropriate approach to decrease the complications of CVD. Randomized controlled trials assessing the effects of curcumin supplementation on endothelial function were included. Two independent authors systematically searched online database including EMBASE, Scopus, PubMed, Cochrane Library, and Web of Science with no time restriction. Cochrane Collaboration risk of bias tool was applied to assess the methodological quality of included trials. Between-study heterogeneities were estimated using the Cochran's Q test and I-square (I2 ) statistic. Data were pooled using a random-effects model, and weighted mean differences (WMDs) were considered as the overall effect sizes. Ten studies with 11 effect sizes were included. We found a significant increase in flow-mediated dilation (FMD) following curcumin supplementation (WMD: 1.49; 95% CI [0.16, 2.82]). There was no effect of curcumin supplement on pulse wave velocity (PWV; WMD: -41.59; 95% CI [-86.59, 3.42]), augmentation index (Aix; WMD: 0.71; 95% CI [-1.37, 2.79]), endothelin-1 (ET-1; WMD: -0.30; 95% CI [-0.96, 0.37]), and soluble intercellular adhesion molecule-1 (sICAM-1; WMD: -10.11; 95% CI [-33.67, 13.46]). This meta-analysis demonstrated the beneficial effects of curcumin supplementation on improving FMD, though it did not influence PWV, Aix, Et-1, and sICAM-1.
Related Concept Videos
Random and Systematic Errors
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Statistical Software for Data Analysis and Clinical Trials
Transfer Function in Control Systems
To derive the transfer function, consider a general nth-order linear time-invariant...
Clinical Trials
There are four phases in a clinical trial. A phase one...

